Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases

• Published in: Journal of nanobiotechnology Vol. 22; no. 1; pp. 354 - 28
• Main Authors: Liu, Xin, Huang, Keke, Zhang, Fuxiao, Huang, Ge, Wang, Lu, Wu, Guiyu, Ren, Hui, Yang, Guang, Lin, Zhiqing
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 20.06.2024; BioMed Central; BMC
• Subjects: Animals; Drug delivery; Drug delivery systems; Drug Delivery Systems - methods; Drug therapy; Drugs; Fundus neovascular disease; Fundus Oculi; Health aspects; Humans; Multifunctional Nanoparticles - chemistry; Nano-in-micro (NIM) delivery system; Nanomedicine - methods; Nanoparticles; Nanoparticles - chemistry; Neovascularization; Neovascularization, Pathologic - drug therapy; Quantum Dots - chemistry; Retinal diseases; Retinal Neovascularization - drug therapy; Review; Technology application; Vehicles; China; Nanoparticles; Nano-in-micro (NIM) delivery system; Drug delivery; Fundus neovascular disease
• ISSN: 1477-3155; 1477-3155
• DOI: 10.1186/s12951-024-02614-1

Fundus neovascularization diseases are a series of blinding eye diseases that seriously impair vision worldwide. Currently, the means of treating these diseases in clinical practice are continuously evolving and have rapidly revolutionized treatment opinions. However, key issues such as inadequate treatment effectiveness, high rates of recurrence, and poor patient compliance still need to be urgently addressed. Multifunctional nanomedicine can specifically respond to both endogenous and exogenous microenvironments, effectively deliver drugs to specific targets and participate in activities such as biological imaging and the detection of small molecules. Nano-in-micro (NIM) delivery systems such as metal, metal oxide and up-conversion nanoparticles (NPs), quantum dots, and carbon materials, have shown certain advantages in overcoming the presence of physiological barriers within the eyeball and are widely used in the treatment of ophthalmic diseases. Few studies, however, have evaluated the efficacy of NIM delivery systems in treating fundus neovascular diseases (FNDs). The present study describes the main clinical treatment strategies and the adverse events associated with the treatment of FNDs with NIM delivery systems and summarizes the anatomical obstacles that must be overcome. In this review, we wish to highlight the principle of intraocular microenvironment normalization, aiming to provide a more rational approach for designing new NIM delivery systems to treat specific FNDs.